Gastroenterologic and General Surgery

Research output

Research output per year 1973 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 1401 Article
• 132 Review article
• 90 Comment/debate
• 72 Editorial
• 138 More
  • 61 Letter
  • 55 Chapter
  • 7 Foreword/postscript
  • 7 Short survey
  • 5 Conference contribution
  • 3 Book

Research output per year

Research output per year

Search results

• 2024

  A new era of risk prediction for patients with high-risk melanoma

  Olofsson Bagge, R. & Hieken, T. J., Apr 2024, In: The Lancet Oncology. 25, 4, p. 415-416 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• APRI score is not predictive of post-surgical outcomes in cholangiocarcinoma patients

  Aslam, F. N., Loveday, T. A., Junior, P. L. S. U., Truty, M., Smoot, R., Bekaii-Saab, T., Stucky, C. C., Babiker, H. & Borad, M. J., Jan 23 2024, In: Annals of Gastroenterology. 37, 1, p. 95-103 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Cholangiocarcinoma 100%
  • Transaminases 90%
  • Blood Platelets 67%
  • Fibrosis 24%
  • Neoplasms 13%

• ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers

  Lohani, K. R., Hoskin, T. L., Day, C. N., Yasir, S., Boughey, J. C. & Degnim, A. C., Feb 2024, In: Annals of surgical oncology. 31, 2, p. 1008-1009 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms 100%
  • Neoplasms 12%

• ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas

  Fogliati, A. & Truty, M. J., 2024, (Accepted/In press) In: Annals of surgical oncology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• ASO Visual Abstract: Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer

  Schulze, A. K., Hoskin, T. L., Moldoveanu, D., Sturz, J. L. & Boughey, J. C., Feb 1 2024, In: Annals of surgical oncology. 31, 2, p. 1025-1026 2 p.

  Research output: Contribution to journal › Article › peer-review

• ASO Visual Abstract: Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients

  Lohani, K. R., Hoskin, T. L., Day, C. N., Yasir, S., Boughey, J. C. & Degnim, A. C., Feb 1 2024, In: Annals of surgical oncology. 31, 2, p. 1027-1028 2 p.

  Research output: Contribution to journal › Article › peer-review

• Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer

  Steadman, J. A., Hoskin, T. L., Klassen, C., Boughey, J. C., Degnim, A. C., Piltin, M. A., Mrdutt, M. M., Johnson, J. E. & Hieken, T. J., Mar 2024, In: Surgery (United States). 175, 3, p. 677-686 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Prophylactic Mastectomy 100%
  • Unilateral Breast Neoplasms 99%
  • Breast 49%
  • Guidelines 42%
  • Mastectomy 11%

• Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era

  Sherman, M. E., Vierkant, R. A., Winham, S. J., Vachon, C. M., Carter, J. M., Pacheco-Spann, L., Jensen, M. R., McCauley, B. M., Hoskin, T. L., Seymour, L., Gehling, D., Fischer, J., Ghosh, K., Radisky, D. C. & Degnim, A. C., Feb 14 2024, In: JAMA surgery. 159, 2, p. 193-201 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Diseases 100%
  • Breast Neoplasms 51%
  • Biopsy 48%
  • Carcinoma, Intraductal, Noninfiltrating 20%
  • Hyperplasia 20%

• Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

  Asumda, F. Z., Campbell, N. A., Hassan, M. A., Fathi, R., Vasquez Rico, D. F., Kiem, M., Vang, E. V., Kim, Y. H., Luo, X., O’Brien, D. R., Buhrow, S. A., Reid, J. M., Moore, M. J., Ben-Yair, V. K., Levitt, M. L., Leiting, J. L., Abdelrahman, A. M., Zhu, X., Lucien, F., Truty, M. J., & 1 othersRoberts, L. R., Mar 2024, In: Cancers. 16, 5, 1050.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes

  Steadman, J. A., Glasgow, A. E., Neequaye, N. N., Habermann, E. B. & Hieken, T. J., 2024, (Accepted/In press) In: Journal of Surgical Oncology.

  Research output: Contribution to journal › Review article › peer-review

  • African Continental Ancestry Group 100%
  • Melanoma 84%
  • Survival 28%
  • Neoplasms 21%
  • European Continental Ancestry Group 15%

• Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection

  Zironda, A., Zhang, C., Day, C., McWilliams, R. R., Starlinger, P., Warner, S. G., Smoot, R. L., Cleary, S. P., Kendrick, M. L., Truty, M. J. & Thiels, C. A., Jan 2024, In: HPB. 26, 1, p. 145-153 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Pancreatic Neoplasms 100%
  • Adenocarcinoma 82%
  • Neoadjuvant Therapy 10%
  • Survival 9%
  • Sex Characteristics 8%

• Endocrine-Sensitive Disease Rate in Postmenopausal Patients with Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

  Ma, C. X., Suman, V. J., Sanati, S., Vij, K., Anurag, M., Leitch, A. M., Unzeitig, G. W., Hoog, J., Fernandez-Martinez, A., Fan, C., Gibbs, R. A., Watson, M. A., Dockter, T. J., Hahn, O., Guenther, J. M., Caudle, A., Crouch, E., Tiersten, A., Mita, M., Razaq, W., & 10 othersHieken, T. J., Wang, Y., Rimawi, M. F., Weiss, A., Winer, E. P., Hunt, K. K., Perou, C. M., Ellis, M. J., Partridge, A. H. & Carey, L. A., Mar 21 2024, In: JAMA Oncology. 10, 3, p. 362-371 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Anastrozole 100%
  • Fulvestrant 92%
  • Endocrine System Diseases 92%
  • Phase III Clinical Trials 83%
  • Estrogen Receptors 64%

• Germline Testing in Patients with Breast Cancer: ASCO-Society of Surgical Oncology Guideline

  Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., Norquist, B. S., Plichta, J. K., Rodriguez, P., Shah, P. D., Tischkowitz, M., Wood, M., Yadav, S., Yao, K. & Robson, M. E., Feb 10 2024, In: Journal of Clinical Oncology. 42, 5, p. 584-604 21 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Surgical Oncology 100%
  • Guidelines 46%
  • Breast Neoplasms 46%
  • Poly(ADP-ribose) Polymerase Inhibitors 21%
  • Penetrance 18%

• Identification of a Notch transcriptomic signature for breast cancer

  Braune, E. B., Geist, F., Tang, X., Kalari, K., Boughey, J., Wang, L., Leon-Ferre, R. A., D’Assoro, A. B., Ingle, J. N., Goetz, M. P., Kreis, J., Wang, K., Foukakis, T., Seshire, A., Wienke, D. & Lendahl, U., Dec 2024, In: Breast Cancer Research. 26, 1, 4.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Breast Neoplasms 100%
  • Datasets 41%
  • Genes 28%
  • Amyloid Precursor Protein Secretases 21%
  • Cell Line 20%

• Idiopathic Granulomatous Mastitis

  Dilaveri, C., Degnim, A., Lee, C., Desimone, D., Moldoveanu, D. & Ghosh, K., 2024, In: Breast Journal. 2024, 6693720.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Granulomatous Mastitis 100%
  • Steroids 44%
  • Corynebacterium 26%
  • Biopsy 24%
  • Granuloma 20%

• Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I–III MIDLC Patients

  Lohani, K. R., Hoskin, T. L., Day, C. N., Yasir, S., Boughey, J. C. & Degnim, A. C., Feb 2024, In: Annals of surgical oncology. 31, 2, p. 936-946 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Breast Neoplasms 100%
  • Neoplasms 50%
  • Nonparametric Statistics 12%
  • Survival 10%
  • Hormones 9%

• Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial

  Hieken, T. J., Nelson, G. D., Flotte, T. J., Grewal, E. P., Chen, J., McWilliams, R. R., Kottschade, L. A., Yang, L., Domingo-Musibay, E., Dronca, R. S., Yan, Y., Markovic, S. N., Dimou, A., Montane, H. N., Erskine, C. L., Piltin, M. A., Price, D. L., Khariwala, S. S., Hui, J., Strand, C. A., & 4 othersHarrington, S. M., Suman, V. J., Dong, H. & Block, M. S., Dec 2024, In: Nature communications. 15, 1, 1430.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cobimetinib 100%
  • Vemurafenib 85%
  • atezolizumab 73%
  • Melanoma 38%
  • Lymph Node Excision 30%

• Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery

  Albain, K. S., Yau, C., Petricoin, E. F., Wolf, D. M., Lang, J. E., Chien, A. J., Haddad, T., Forero-Torres, A., Wallace, A. M., Kaplan, H., Pusztai, L., Euhus, D., Nanda, R., Elias, A. D., Clark, A. S., Godellas, C., Boughey, J. C., Isaacs, C., Tripathy, D., Lu, J., & 29 othersYung, R. L., Gallagher, R. I., Wulfkuhle, J. D., Brown-Swigart, L., Krings, G., Chen, Y. Y., Potter, D. A., Stringer-Reasor, E., Blair, S., Asare, S. M., Wilson, A., Hirst, G. L., Singhrao, R., Buxton, M., Clennell, J. L., Sanil, A., Berry, S., Asare, A. L., Matthews, J. B., DeMichele, A. M., Hylton, N. M., Melisko, M., Perlmutter, J., Rugo, H. S., Symmans, W. F., van't Veer, L. J., Yee, D., Berry, D. A. & Esserman, L. J., Feb 15 2024, In: Clinical Cancer Research. 30, 4, p. 729-740 12 p.

  Research output: Contribution to journal › Article › peer-review

  • trebananib 100%
  • Paclitaxel 52%
  • Biomarkers 33%
  • Breast Neoplasms 33%
  • TIE-2 Receptor 31%

• Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

  Moldoveanu, D., Hoskin, T. L., Day, C. N., Schulze, A. K., Goetz, M. P. & Boughey, J. C., Feb 2024, In: Breast Cancer Research and Treatment. 203, 3, p. 419-428 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Breast Neoplasms 100%
  • Drug Therapy 92%
  • Survival 86%
  • Disease Eradication 36%
  • Breast 19%

• Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma

  Fogliati, A., Zironda, A., Fiorentini, G., Adjei, S., Amro, A., Starlinger, P. P., Grotz, T. E., Warner, S. G., Smoot, R. L., Thiels, C. A., Kendrick, M. L., Cleary, S. P. & Truty, M. J., Apr 2024, In: Annals of surgical oncology. 31, 4, p. 2632-2639 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adenocarcinoma 100%
  • Drug Therapy 75%
  • Neoplasms 41%
  • Neoadjuvant Therapy 40%
  • Disease-Free Survival 21%

• Participant Evaluation of a Multi-disciplinary Oncology Preceptorship Training Program for Oncology Health Professionals from Kumasi, Ghana

  Merrell, K. W., Konney, T. O., Acheamfour, O., Lucido, J., Aduse-Poku, A. Y., Kumar, A., Ansah, M. B., Amankwa, A. T., Shumway, D., Awittor, F. K., Badu-Peprah, A., Fonkoua, L. A. A. K., Hendrickson, A. E. W., Boakye, E., Adjei, E. K., Kyei, I., Kemper, K., Rank, M., Peethambaram, P. P., Spangenberg, K., & 12 othersSorenson, K., Hearrold, M., Garda, A., Graham, R., Lang, K., Adom, J., Achiaa, R., Jakub, J., Amo, B. D., Osei-Bonsu, E., Camacho, R. & Addison, E. C. D. K., 2024, (Accepted/In press) In: Journal of Cancer Education.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer

  Alkhatib, H., Conage-Pough, J., Roy Chowdhury, S., Shian, D., Zaid, D., Rubinstein, A. M., Sonnenblick, A., Peretz-Yablonsky, T., Granit, A., Carmon, E., Kohale, I. N., Boughey, J. C., Goetz, M. P., Wang, L., White, F. M. & Kravchenko-Balasha, N., Dec 2024, In: Molecular cancer. 23, 1, 17.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • Triple Negative Breast Neoplasms 100%
  • Neoplasms 14%
  • Therapeutics 13%
  • Thermodynamics 11%
  • Progesterone Receptors 9%

• Pregnancy-associated melanoma: characteristics and outcomes from 2002 to 2020

  Davidson, T. M., Hieken, T. J., Glasgow, A. E., Habermann, E. B. & Yan, Y., Apr 1 2024, In: Melanoma research. 34, 2, p. 175-181 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Melanoma 100%
  • Pregnancy 72%
  • Lysergic Acid Diethylamide 26%
  • Guidelines 12%
  • Survival 11%

• Rare Presentation of Papillary Carcinoma Within a Sentinel Lymph Node in a Patient With Ductal Carcinoma in Situ of the Breast: A Challenging but Useful Case Report Discussion Regarding Displacement or True Metastasis?

  Sonam, F., Komforti, M. K., Jakub, J. W., Cornell, L. F. & Robinson, K. A., 2024, (Accepted/In press) In: International Journal of Surgical Pathology.

  Research output: Contribution to journal › Article › peer-review

• Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy

  Schulze, A. K., Hoskin, T. L., Mrdutt, M. M., Mutter, R. W. & Hieken, T. J., Mar 2024, In: Journal of Surgical Oncology. 129, 3, p. 461-467 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Sentinel Lymph Node 100%
  • Mastectomy 89%
  • Breast Neoplasms 52%
  • Recurrence 20%
  • Lymphoscintigraphy 12%

• Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks

  Singh, P., Agnese, D., Amin, M., Barrio, A. V., Botty Van den Bruele, A., Burke, E., Danforth, D. N., Dirbas, F. M., Eladoumikdachi, F., Kantor, O., Kumar, S., Lee, M. C., Matsen, C., Nguyen, T. T., Ozmen, T., Park, K. U., Plichta, J. K., Reyna, C., Showalter, S. L., Styblo, T., & 4 othersTranakas, N., Weiss, A., Laronga, C. & Boughey, J., Apr 2024, In: Annals of surgical oncology. 31, 4, p. 2212-2223 12 p.

  Research output: Contribution to journal › Review article › peer-review

  • Surgical Oncology 100%
  • Breast Diseases 90%
  • Mastectomy 80%
  • Breast Neoplasms 18%
  • Unilateral Breast Neoplasms 11%

• SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?

  Jakub, J. W., Advani, P., Maxwell, R., Vallow, L., Maimone, S. & McLaughlin, S., 2024, (Accepted/In press) In: Annals of surgical oncology.

  Research output: Contribution to journal › Article › peer-review

• The “double-fired” gastro-jejunostomy as a form of improved efficiency during Whipple procedure

  Fiorentini, G., Zironda, A., Fogliati, A., Warner, S., Cleary, S., Smoot, R., Truty, M., Kendrick, M., Nagorney, D., Thiels, C. & Starlinger, P., Apr 2024, In: HPB. 26, 4, p. 512-520 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Jejunostomy 100%
  • Hand 55%
  • Pancreaticoduodenectomy 35%
  • Operative Time 23%
  • Gastric Emptying 13%

• Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer

  Schulze, A. K., Hoskin, T. L., Moldoveanu, D., Sturz, J. L. & Boughey, J. C., Feb 2024, In: Annals of surgical oncology. 31, 2, p. 947-956 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Unilateral Breast Neoplasms 100%
  • Breast Neoplasms 42%
  • Disease-Free Survival 31%
  • Neoplasms 21%
  • Carcinoma, Intraductal, Noninfiltrating 15%
• 2023

  Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection

  Zhang, C., Gudmundsdottir, H., Takahashi, H., Day, C., Glasgow, A., Wasif, N., Starlinger, P., Warner, S., Grotz, T., Smoot, R., Truty, M., Cleary, S., Kendrick, M., Nagorney, D., Navin, P., Halfdanarson, T. R. & Thiels, C., Dec 2023, In: Journal of Surgical Oncology. 128, 7, p. 1072-1079 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neuroendocrine Tumors 100%
  • Positron-Emission Tomography 82%
  • Neoplasm Metastasis 43%
  • Palpation 40%
  • Gallium-68 30%

• Ampullary Adenocarcinoma, Version 1.2023

  Chiorean, E. G., Chiaro, M. D., Tempero, M. A., Malafa, M. P., Benson, A. B., Cardin, D. B., Christensen, J. A., Chung, V., Czito, B., Dillhoff, M., Donahue, T. R., Dotan, E., Fountzilas, C., Glazer, E. S., Hardacre, J., Hawkins, W. G., Klute, K., Ko, A. H., Kunstman, J. W., LoConte, N., & 19 othersLowy, A. M., Masood, A., Moravek, C., Nakakura, E. K., Narang, A. K., Nardo, L., Obando, J., Polanco, P. M., Reddy, S., Reyngold, M., Scaife, C., Shen, J., Truty, M. J., Vollmer, C., Wolff, R. A., Wolpin, B. M., McCullough, B., Lubin, S. & Darlow, S. D., Jul 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 7, p. 753-782 30 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adenocarcinoma 100%
  • Ampulla of Vater 77%
  • Neoplasms 41%
  • Bile Ducts 37%
  • Gastrointestinal Neoplasms 21%

• An international multi-institution real-world study of the optimal surveillance frequency for stage II/III gastric cancer: the more, the better?

  Wu, D., Lu, J., Lin, J., Xu, B. B., Xue, Z., Zheng, H. L., Lin, G. S., Huang, J. B., Shen, L. L., Zheng, C. H., Li, P., Xie, J. W., Wang, J. B., Lin, J. X., Chen, Q. Y., Cao, L. L., Ma, Y. B., Truty, M. J. & Huang, C. M., Dec 1 2023, In: International Journal of Surgery. 109, 12, p. 4101-4112 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Stomach Neoplasms 100%
  • Quality-Adjusted Life Years 21%
  • Guidelines 18%
  • China 15%
  • Forests 11%

• Anorectal melanoma

  Fastner, S., Hieken, T. J., McWilliams, R. R. & Hyngstrom, J., Sep 15 2023, In: Journal of Surgical Oncology. 128, 4, p. 635-644 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Melanoma 100%
  • Skin 18%
  • Radiotherapy 11%
  • Population 6%
  • Therapeutics 5%

• A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large-Sample Retrospective Study

  Que, S. J., Zhong, Q., Chen, Q. Y., Truty, M. J., Yan, S., Ma, Y. B., Ding, F. H., Zheng, C. H., Li, P., Wang, J. B., Lin, J. X., Lu, J., Cao, L. L., Lin, M., Tu, R. H., Lin, J. L., Zheng, H. L. & Huang, C. M., Jul 2023, In: World Journal of Surgery. 47, 7, p. 1762-1771 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Neoadjuvant Therapy 100%
  • imidazole mustard 94%
  • Stomach Neoplasms 75%
  • Retrospective Studies 58%
  • University Hospitals 45%

• ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer

  Huang, K., Jakub, J. W. & McLaughlin, S. A., Dec 2023, In: Annals of surgical oncology. 30, 13, p. 8455-8456 2 p.

  Research output: Contribution to journal › Article › peer-review

• ASO Author Reflections: Axillary Reverse Mapping: Where Do We Go from Here?

  Benolken, M. M. & Jakub, J. W., Oct 2023, In: Annals of surgical oncology. 30, 10, p. 6051-6052 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management

  Moldoveanu, D., Goetz, M. P. & Boughey, J. C., Oct 2023, In: Annals of surgical oncology. 30, 11, p. 6484-6485 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years-Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial

  Boughey, J. C., Yu, H., Dugan, C. L., Piltin, M. A., Postlewait, L., Son, J. D., Edmiston, K. K., Godellas, C., Lee, M. C., Carr, M. J., Tonneson, J. E., Crown, A., Lancaster, R. B., Woriax, H. E., Ewing, C. A., Chau, H. S., Patterson, A. K., Wong, J. M., Alvarado, M. D., Yang, R. L., & 17 othersChan, T. W., Sheade, J. B., Ahrendt, G. M., Larson, K. E., Switalla, K., Tuttle, T. M., Tchou, J. C., Rao, R., Tamirisa, N., Singh, P., Gould, R. E., Terando, A., Sauder, C., Hewitt, K., Chiba, A., Esserman, L. J. & Mukhtar, R., Oct 1 2023, In: Annals of surgical oncology. 30, 11, p. 6411-6412 2 p.

  Research output: Contribution to journal › Article › peer-review

• ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer

  Huang, K., Jakub, J., Gabriel, E., Moreno-Aspitia, A. & McLaughlin, S., Nov 1 2023, In: Annals of surgical oncology. 30, 12, p. 7143 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer

  Hunt, K. K., Suman, V. J., Wingate, H. F., Leitch, A. M., Unzeitig, G., Boughey, J. C., Meric-Bernstam, F., Ellis, M. J. & Olson, J. A., Apr 1 2023, In: Annals of surgical oncology. 30, 4, p. 2119-2120 2 p.

  Research output: Contribution to journal › Article › peer-review

• ASO Visual Abstract: Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis-Results from a Prospective Pilot Study

  Grotz, T. E., Yonkus, J. A., Thiels, C. A., Warner, S. G., McWilliams, R., Mahipal, A., Bekaii-Saab, T. S., Cleary, S. P., Kendrick, M. L. & Truty, M. J., Sep 1 2023, In: Annals of surgical oncology. 30, 9, p. 5765 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer

  Moldoveanu, D., Hoskin, T. L., Day, C. N., Schulze, A. K., Goetz, M. P. & Boughey, J. C., Oct 1 2023, In: Annals of surgical oncology. 30, 11, p. 6486-6487 2 p.

  Research output: Contribution to journal › Article › peer-review

• ASO Visual Abstract: Lymph Node Positivity of Axillary Reverse Mapping Lymph Nodes at Time of Axillary Lymph Node Dissection, 2 Site Prospective Trial

  Benolken, M. M., McLaughlin, S., Piltin, M., Mrdutt, M., Li, Z. & Jakub, J. W., Oct 1 2023, In: Annals of surgical oncology. 30, 10, p. 6050 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases-Long-Term Follow-Up of Over 500 Patients

  Gudmundsdottir, H., Habermann, E. B., Vierkant, R. A., Starlinger, P., Thiels, C. A., Warner, S. G., Smoot, R. L., Truty, M. J., Kendrick, M. L., Halfdanarson, T. R., Nagorney, D. M. & Cleary, S. P., Aug 1 2023, In: Annals of surgical oncology. 30, 8, p. 4854-4855 2 p.

  Research output: Contribution to journal › Article › peer-review

• Automated Artificial Intelligence Model Trained on a Large Data Set Can Detect Pancreas Cancer on Diagnostic Computed Tomography Scans As Well As Visually Occult Preinvasive Cancer on Prediagnostic Computed Tomography Scans

  Korfiatis, P., Suman, G., Patnam, N. G., Trivedi, K. H., Karbhari, A., Mukherjee, S., Cook, C., Klug, J. R., Patra, A., Khasawneh, H., Rajamohan, N., Fletcher, J. G., Truty, M. J., Majumder, S., Bolan, C. W., Sandrasegaran, K., Chari, S. T. & Goenka, A. H., Dec 2023, In: Gastroenterology. 165, 6, p. 1533-1546.e4

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Artificial Intelligence 100%
  • Pancreatic Neoplasms 71%
  • Datasets 59%
  • Adenocarcinoma 59%
  • Tomography 51%

• Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort

  Sherman, M. E., Vierkant, R. A., Masters, M., Radisky, D. C., Winham, S. J., Degnim, A. C., Vachon, C. M., Patel, A. V. & Teras, L. R., Mar 1 2023, In: Cancer Prevention Research. 16, 3, p. 175-184 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Breast Diseases 100%
  • Non-Steroidal Anti-Inflammatory Agents 86%
  • Cohort Studies 54%
  • Breast Neoplasms 51%
  • Neoplasms 25%

• Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs

  Mukherjee, S., Korfiatis, P., Khasawneh, H., Rajamohan, N., Patra, A., Suman, G., Singh, A., Thakkar, J., Patnam, N. G., Trivedi, K. H., Karbhari, A., Chari, S. T., Truty, M. J., Halfdanarson, T. R., Bolan, C. W., Sandrasegaran, K., Majumder, S. & Goenka, A. H., Aug 2023, In: Pancreatology. 23, 5, p. 522-529 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Standard of Care 100%
  • Adenocarcinoma 80%
  • Pancreas 44%
  • Neoplasms 33%
  • Datasets 30%

• Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence after Neoadjuvant Chemotherapy: Results from 1462 Patients on the Prospective, Randomized I-SPY2 Trial

  Mukhtar, R. A., Chau, H., Woriax, H., Piltin, M., Ahrendt, G., Tchou, J., Yu, H., Ding, Q., Dugan, C. L., Sheade, J., Crown, A., Carr, M., Wong, J., Son, J., Yang, R., Chan, T., Terando, A., Alvarado, M., Ewing, C., Tonneson, J., & 13 othersTamirisa, N., Gould, R., Singh, P., Godellas, C., Larson, K., Chiba, A., Rao, R., Sauder, C., Postlewait, L., Lee, M. C., Symmans, W. F., Esserman, L. J. & Boughey, J. C., Sep 1 2023, In: Annals of surgery. 278, 3, p. 320-327 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Mastectomy 100%
  • Breast 68%
  • Drug Therapy 53%
  • Recurrence 51%
  • Segmental Mastectomy 47%

• Cancer "Avatars": Patient-Derived Xenograft Growth Correlation with Postoperative Recurrence and Survival in Pancreaticobiliary Cancer

  Lynch, I. T., Abdelrahman, A. M., Alva-Ruiz, R., Fogliati, A., Graham, R. P., Smoot, R. & Truty, M. J., Sep 1 2023, In: Journal of the American College of Surgeons. 237, 3, p. 483-500 18 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Heterografts 100%
  • Recurrence 63%
  • Survival 61%
  • Growth 56%
  • Neoplasms 35%

• Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial

  Boughey, J. C., Yu, H., Dugan, C. L., Piltin, M. A., Postlewait, L., Son, J. D., Edmiston, K. K., Godellas, C. V., Lee, M. C., Carr, M. J., Tonneson, J. E., Crown, A., Lancaster, R. B., Woriax, H. E., Ewing, C. A., Chau, H. S., Patterson, A. K., Wong, J. M., Alvarado, M. D., Yang, R. L., & 17 othersChan, T. W., Sheade, J. B., Ahrendt, G. M., Larson, K. E., Switalla, K., Tuttle, T. M., Tchou, J. C., Rao, R., Tamirisa, N., Singh, P., Gould, R. E., Terando, A., Sauder, C., Hewitt, K., Chiba, A., Esserman, L. J. & Mukhtar, R. A., Oct 2023, In: Annals of surgical oncology. 30, 11, p. 6401-6410 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Axilla 100%
  • Sentinel Lymph Node 90%
  • Lymph Node Excision 81%
  • Breast Neoplasms 53%
  • Drug Therapy 49%